{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:38:01Z","timestamp":1767904681451,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jchromb.2017.03.024","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T16:45:37Z","timestamp":1490373937000},"page":"101-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Determination and quantification of intracellular fludarabine triphosphate, cladribine triphosphate and clofarabine triphosphate by LC\u2013MS\/MS in human cancer cells"],"prefix":"10.1016","volume":"1053","author":[{"given":"Jean-Yves","family":"Puy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars Petter","family":"Jordheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emeline","family":"Cros-Perrial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Dumontet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Peyrottes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Lefebvre-Tournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2017.03.024_bib0005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd4010","article-title":"Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases","volume":"12","author":"Jordheim","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0010","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.leu.2402114","article-title":"Nucleoside analogues: mechanisms of drug resistance and reversal strategies","volume":"15","author":"Galmarini","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.jchromb.2017.03.024_bib0015","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.2174\/092986708784221449","article-title":"Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy","volume":"15","author":"Galmarini","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1200\/JCO.1992.10.3.371","article-title":"2-chlorodeoxyadenosine treatment of low-grade lymphomas","volume":"10","author":"Kay","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0025","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1182\/blood.V72.3.1069.bloodjournal7231069","article-title":"2-chlorodeoxyadenosine \u2013 an effective new agent for the treatment of chronic lymphocytic-leukemia","volume":"72","author":"Piro","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jchromb.2017.03.024_bib0030","doi-asserted-by":"crossref","first-page":"U852","DOI":"10.1038\/nrd2055","article-title":"Discovery and development of clofarabine: a nucleoside analogue for treating cancer","volume":"5","author":"Bonate","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2141.2000.01850.x","article-title":"Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia \u2013 updated results of the multicentre study of 378 patients","volume":"108","author":"Robak","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0040","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/0006-2952(77)90275-1","article-title":"Biologic activity of 9-beta-d-arabinofuranosyl-2-fluoroadenine \u2013 metabolically stable analog of 9-beta-d-arabinofuranosyladenine","volume":"26","author":"Brockman","year":"1977","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00262285","article-title":"9-beta-d-arabinofuranosyl-2-fluoroadenine 5'-monophosphate pharmacokinetics in plasma and tumor-cells of patients with relapsed leukemia and lymphoma","volume":"18","author":"Danhauser","year":"1986","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0050","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1073\/pnas.89.7.2970","article-title":"Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine","volume":"89","author":"Carson","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0055","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1073\/pnas.81.7.2232","article-title":"Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine","volume":"81","author":"Carson","year":"1984","journal-title":"Proc. Natl. Acad. Ssi. U S A"},{"key":"10.1016\/j.jchromb.2017.03.024_bib0060","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1073\/pnas.76.5.2430","article-title":"Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human t-cell lines","volume":"76","author":"Carson","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0065","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(02)00788-X","article-title":"Nucleoside analogues and nucleobases in cancer treatment","volume":"3","author":"Galmarini","year":"2002","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0070","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1021\/jm00080a029","article-title":"Synthesis and biologic activity of 2'-fluoro-2-halo derivatives of 9-beta-d-arabinofuranosyladenine","volume":"35","author":"Montgomery","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0075","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1124\/mol.105.015768","article-title":"A comparison of the transportability, and its role in cytotoxicity of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems","volume":"69","author":"King","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0080","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/17425255.3.5.705","article-title":"The role of mitochondrial and plasma membrane nucleoside transporters in drug toxicity","volume":"3","author":"Leung","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0085","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1074\/jbc.M007746200","article-title":"Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib)","volume":"276","author":"Ritzel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0090","first-page":"4349","article-title":"Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines","volume":"58","author":"Mackey","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0095","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1124\/mol.53.2.270","article-title":"Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs","volume":"53","author":"Sjoberg","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0100","doi-asserted-by":"crossref","first-page":"22847","DOI":"10.1016\/S0021-9258(18)41605-5","article-title":"Substrate-specificity of mitochondrial 2'-deoxyguanosine kinase \u2212 efficient phosphorylation of 2-chlorodeoxyadenosine","volume":"268","author":"Wang","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0105","first-page":"13","volume":"Vol 341994","author":"Eriksson","year":"2017"},{"key":"10.1016\/j.jchromb.2017.03.024_bib0110","first-page":"2438","article-title":"Biochemical pharmacology and resistance to 2-chloro-2 '-arabinonuoro-2 '-deoxyadenosine, a novel analogue of cladribine in human leukemic cells","volume":"5","author":"Lotfi","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0115","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0026-895X(24)12176-1","article-title":"Comparison of the mechanism of cytotoxicity of 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)adenine 2-chloro-9-(2-deoxy-2-fluoro-beta-d-ribofuranosyl)adenine and 2-chloro-9-(2-deoxy-2,2-difluoro-beta-d-ribofuranosyl)adenine in CEM cells","volume":"55","author":"Parker","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0120","doi-asserted-by":"crossref","first-page":"16617","DOI":"10.1016\/S0021-9258(17)46267-3","article-title":"Termination of DNA-synthesis by 9-beta-d-arabinofuranosyl-2-fluoroadenine \u2013 a mechanism for cytotoxicity","volume":"265","author":"Huang","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0125","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0026-895X(25)09779-2","article-title":"Interaction of 2-halogenated datp analogs (f, cl, and br) with human DNA-polymerases DNA primase, and ribonucleotide reductase","volume":"34","author":"Parker","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0130","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0026-895X(25)14620-8","article-title":"In vitro biological-activity of 9-beta-d-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA-polymerases and ribonucleotide reductase from hela-cells","volume":"21","author":"Tseng","year":"1982","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0135","first-page":"2260","article-title":"Comparison of the actions of 9-beta-d-arabinofuranosyl-2-fluoroadenine and 9-beta-d-arabinofuranosyladenine on target enzymes from mouse-tumor cells","volume":"42","author":"White","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0026-895X(25)10999-1","article-title":"Action of 9-beta-d-arabinofuranosyl-2-fluoroadenine on rna-metabolism","volume":"39","author":"Huang","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0145","first-page":"2386","article-title":"Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)adenine on k562 cellular-metabolism and the inhibition of human ribonucleotide reductase and DNA-polymerases by its 5'-triphosphate","volume":"51","author":"Parker","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003088-200241020-00002","article-title":"Cellular and clinical pharmacology of fludarabine","volume":"41","author":"Gandhi","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0155","first-page":"3030","article-title":"Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)adenine","volume":"56","author":"Xie","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0160","first-page":"6923","article-title":"Mechanisms of inhibition of DNA-synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells","volume":"49","author":"Griffig","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0165","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1124\/jpet.107.128595","article-title":"Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants","volume":"323","author":"Lamba","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jasms.2005.09.001","article-title":"A high-performance liquid chromatography-tandem mass spectrometry method for quantitation of nitrogen-containing intracellular metabolites","volume":"17","author":"Lu","year":"2006","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0175","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1016\/j.chroma.2010.06.014","article-title":"Ion-pair high-performance liquid chromatography with diode array detection coupled to dual electrospray atmospheric pressure chemical ionization time-of-flight mass spectrometry for the determination of nucleotides in baby foods","volume":"1217","author":"Vinas","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2017.03.024_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12010-007-8015-0","article-title":"Separation of cytidine 5'-triphosphate biosynthesized from cytidine 5'-monophosphate on ion-exchange resin and HPLC analysis of cytidine compounds","volume":"144","author":"Shi","year":"2008","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0185","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1016\/j.jchromb.2009.09.030","article-title":"Simultaneous analysis of eight nucleoside triphosphates in cell lines by liquid chromatography coupled with tandem mass spectrometry","volume":"877","author":"Cohen","year":"2009","journal-title":"J. Chromatogr. B-Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0190","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jchromb.2009.02.071","volume":"877","author":"Crauste","year":"2009","journal-title":"J. Chromatogr. B-Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0195","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.foodchem.2016.05.091","article-title":"Determination of nucleosides and nucleotides in baby foods by hydrophilic interaction chromatography coupled to tandem mass spectrometry in the presence of hydrophilic ion-pairing reagents","volume":"211","author":"Mateos-Vivas","year":"2016","journal-title":"Food Chem."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0200","first-page":"129","article-title":"Hydrophilic interaction chromatography coupled to tandem mass spectrometry in the presence of hydrophilic ion-pairing reagents for the separation of nucleosides and nucleotide mono-, di- and triphosphates","volume":"2015","author":"Mateos-Vivas","year":"1414","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2017.03.024_bib0205","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.chroma.2008.01.075","article-title":"Separation efficiencies in hydrophilic interaction chromatography","volume":"1184","author":"Ikegami","year":"2008","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2017.03.024_bib0210","doi-asserted-by":"crossref","first-page":"9918","DOI":"10.1021\/jf102023p","article-title":"Development and application of an HILIC-MS\/MS method for the quantitation of nucleotides in infant formula","volume":"58","author":"Inoue","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.trac.2013.02.011","article-title":"Stationary phases for separation of nucleosides and nucleotides by hydrophilic interaction liquid chromatography","volume":"47","author":"Garcia-Gomez","year":"2013","journal-title":"Trac-Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.aca.2012.06.016","article-title":"A quantitative liquid chromatography tandem mass spectrometry method for metabolomic analysis of Plasmodium falciparum lipid related metabolites","volume":"739","author":"Duy","year":"2012","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2017.03.024_bib0225","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jchromb.2014.01.021","article-title":"A sensitive LC-MS\/MS method for quantifying clofarabine triphosphate concentrations in human peripheral blood mononuclear cells","volume":"964","author":"Tu","year":"2014","journal-title":"J. Chromatogr. B-Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0230","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jpba.2013.08.007","article-title":"Determination of intracellular fludarabine triphosphate in human peripheral blood mononuclear cells by LC-MS\/MS","volume":"86","author":"Huang","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0235","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jchromb.2005.03.034","article-title":"A highly sensitive high-performance liquid chromatography-mass spectrometry method for quantification of fludarabine triphosphate in leukemic cells","volume":"820","author":"Kalhorn","year":"2005","journal-title":"J. Chromatogr. B-Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0240","first-page":"131","article-title":"A new route to nucleoside 5'-triphosphates","volume":"16","author":"Ludwig","year":"1981","journal-title":"Acta Biochim. Biophys. Hung."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0245","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2210-4-8","article-title":"Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene","volume":"4","author":"Galmarini","year":"2004","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0250","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1007\/s00216-015-8757-4","article-title":"Determination of the enzymatic activity of cytosolic 5 '-nucleotidase cN-II in cancer cells: development of a simple analytical method and related cell line models","volume":"407","author":"Jordheim","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0255","series-title":"Guidance for Industry, Bioanalytical Method Validation","author":"US. FDA","year":"2001"},{"key":"10.1016\/j.jchromb.2017.03.024_bib0260","doi-asserted-by":"crossref","first-page":"9815","DOI":"10.1073\/pnas.1013274108","article-title":"Clofarabine 5 '-di and \u2212triphosphates inhibit human ribonucleotide reductase by altering the quaternary structure of its large subunit","volume":"108","author":"Aye","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jchromb.2017.03.024_bib0265","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1158\/1078-0432.CCR-04-0506","article-title":"Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug","volume":"10","author":"Jordheim","year":"2004","journal-title":"Clin. Cancer Res."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023216313241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023216313241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:10:14Z","timestamp":1750180214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023216313241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":53,"alternative-id":["S1570023216313241"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2017.03.024","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination and quantification of intracellular fludarabine triphosphate, cladribine triphosphate and clofarabine triphosphate by LC\u2013MS\/MS in human cancer cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2017.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}